What was Curative Biosciences’s price range in the past 12 months?
Curative Biosciences lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
What is Curative Biosciences’s market cap?
Curative Biosciences’s market cap is $25.79K.
When is Curative Biosciences’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is Curative Biosciences overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Curative Biosciences pay dividends?
Curative Biosciences does not currently pay dividends.
What is Curative Biosciences’s EPS estimate?
Curative Biosciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Curative Biosciences have?
Curative Biosciences has 257,892,270 shares outstanding.
Which hedge fund is a major shareholder of Curative Biosciences?
Currently, no hedge funds are holding shares in CBDX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Curative Biosciences
Curative Biosciences, Inc. focuses on developing and commercializing therapeutics using hemp-derived Cannabidiol. It intends to manufacture and market natural health products and operate in the medical cannabis industry. The company was formerly known as Amaize Beverage Corporation and changed its name to Curative Biosciences, Inc. in August 2017. Curative Biosciences, Inc. was founded in 2009 and is based in Miami, Florida.